Interferon aerosol suppression of vesicular stomatitis virus replication in the lungs of infected mice.
AUTOR(ES)
Wyde, P R
RESUMO
Mice were inoculated intranasally with vesicular stomatitis virus 16 to 22 h after being exposed to small-particle aerosols of saline, natural mouse alpha interferon, recombinant human alpha interferon A, or hybrid recombinant human alpha interferon A/D bgl for 2, 4, or 8 h. Compared with comparably inoculated, untreated mice, significantly reduced levels of vesicular stomatitis virus were observed in the lungs of animals treated with any interferon preparation for 8 h and in groups treated with mouse alpha interferon or hybrid recombinant human alpha interferon A/D bgl for 4 h. No significant reductions in lung virus titers were observed in any group treated with interferon for 2 h or in any of the groups treated with saline.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=179943Documentos Relacionados
- Duration of effect of interferon aerosol prophylaxis of vesicular stomatitis virus infection in mice.
- Interferon production in mice by vesicular stomatitis virus.
- Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice.
- Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice.
- Interferon induction by vesicular stomatitis virus and its role in virus replication.
